Search Results

You are looking at 1 - 10 of 254 items for :

  • papillary carcinoma x
Clear All
Kaoru Kobayashi Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Kaoru Kobayashi in
Google Scholar
PubMed
Close
,
Mitsuyoshi Hirokawa Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Mitsuyoshi Hirokawa in
Google Scholar
PubMed
Close
,
Tomonori Yabuta Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Tomonori Yabuta in
Google Scholar
PubMed
Close
,
Mitsuhiro Fukushima Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Mitsuhiro Fukushima in
Google Scholar
PubMed
Close
,
Minoru Kihara Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Minoru Kihara in
Google Scholar
PubMed
Close
,
Yuuki Takamura Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Yuuki Takamura in
Google Scholar
PubMed
Close
,
Yasuhiro Ito Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Yasuhiro Ito in
Google Scholar
PubMed
Close
,
Akihiro Miya Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Akihiro Miya in
Google Scholar
PubMed
Close
,
Nobuyuki Amino Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Nobuyuki Amino in
Google Scholar
PubMed
Close
, and
Akira Miyauchi Kuma Hospital, Kobe City, Hyogo, Japan

Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
Close

patients with honeycomb-like papillary thyroid carcinoma showing multiple small cysts, and describe the characteristic features on ultrasonography. Methods and Patients Ultrasonographic examination was performed by well-trained registered

Free access
Haggi Mazeh Department of Surgery, Jerusalem, Israel

Search for other papers by Haggi Mazeh in
Google Scholar
PubMed
Close
,
Amir Orlev Department of Surgery, Jerusalem, Israel

Search for other papers by Amir Orlev in
Google Scholar
PubMed
Close
,
Ido Mizrahi Department of Surgery, Jerusalem, Israel

Search for other papers by Ido Mizrahi in
Google Scholar
PubMed
Close
,
David J. Gross Endocrinology and Metabolism Service Hadassah-Hebrew University Medical Center, Jerusalem, Israel

Search for other papers by David J. Gross in
Google Scholar
PubMed
Close
, and
Herbert R. Freund Department of Surgery, Jerusalem, Israel

Search for other papers by Herbert R. Freund in
Google Scholar
PubMed
Close

Introduction Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) are both derived from the thyroid follicular cells. Of the two, PTC is the most common thyroid cancer, accounting for 75-80% of all thyroid

Free access
Daniela Cavaco Department of Endocrinology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Daniela Cavaco in
Google Scholar
PubMed
Close
,
Sara Carvalhal Department of General Surgery, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal

Search for other papers by Sara Carvalhal in
Google Scholar
PubMed
Close
, and
Valeriano Leite Department of Endocrinology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal
NOVA Medical School/Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Close

life. Metastatic papillary thyroid carcinoma (PTC) with cutaneous metastases may cause pain, ulceration, and bleeding. Novel Insights ECT seems to be a safe and effective technique and may be an option for local palliative

Free access
Filipe Pereira Clinical and Experimental Endocrinology, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto, Porto

Search for other papers by Filipe Pereira in
Google Scholar
PubMed
Close
,
Sofia S. Pereira Clinical and Experimental Endocrinology, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto, Porto
Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto

Search for other papers by Sofia S. Pereira in
Google Scholar
PubMed
Close
,
Marta Mesquita Serviço de Anatomia Patológica, Instituto Português Oncologia de Lisboa, Francisco Gentil, Lisbon

Search for other papers by Marta Mesquita in
Google Scholar
PubMed
Close
,
Tiago Morais Clinical and Experimental Endocrinology, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto, Porto

Search for other papers by Tiago Morais in
Google Scholar
PubMed
Close
,
Madalena M. Costa Clinical and Experimental Endocrinology, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto, Porto

Search for other papers by Madalena M. Costa in
Google Scholar
PubMed
Close
,
Pedro Quelhas Instituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto
Instituto de Engenharia Biomédica (INEB), Universidade do Porto, Porto

Search for other papers by Pedro Quelhas in
Google Scholar
PubMed
Close
,
Carlos Lopes Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP)
Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto

Search for other papers by Carlos Lopes in
Google Scholar
PubMed
Close
,
Mariana P. Monteiro Clinical and Experimental Endocrinology, Multidisciplinary Unit for Biomedical Research (UMIB), ICBAS, University of Porto, Porto

Search for other papers by Mariana P. Monteiro in
Google Scholar
PubMed
Close
, and
Valeriano Leite Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal
Serviço de Endocrinologia, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Close

Introduction Malignant thyroid tumors provide a good model to study the mechanisms underlying the metastatic process. The most prevalent thyroid tumors are papillary (PTC) and follicular (FTC) carcinomas. Although both originate from

Free access
Hao Li Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Otorhinolaryngology, Tan Tock Seng Hospital, Singapore, Singapore

Search for other papers by Hao Li in
Google Scholar
PubMed
Close
,
Nir Livneh Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Otolaryngology, Head and Neck Surgery, Sheba Medical Center, Ramat Gan, Israel

Search for other papers by Nir Livneh in
Google Scholar
PubMed
Close
,
Snjezana Dogan Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Snjezana Dogan in
Google Scholar
PubMed
Close
, and
Ashok R. Shaha Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA

Search for other papers by Ashok R. Shaha in
Google Scholar
PubMed
Close

Introduction Papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC) are thyroid neoplasms derived from different cell types. While the former is common, the latter is much less frequent [ 1 , 2 ]. The synchronous occurrence

Free access
Pedro Marques Endocrinology Department, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal

Search for other papers by Pedro Marques in
Google Scholar
PubMed
Close
,
Valeriano Leite Endocrinology Department, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal

Search for other papers by Valeriano Leite in
Google Scholar
PubMed
Close
, and
Maria João Bugalho Endocrinology Department, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal
NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal

Search for other papers by Maria João Bugalho in
Google Scholar
PubMed
Close

Introduction Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. The widespread use of neck ultrasound (US) has led to the identification of small asymptomatic thyroid nodules with indeterminate clinical relevance [ 1

Free access
Sule Canberk Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal

Search for other papers by Sule Canberk in
Google Scholar
PubMed
Close
,
Joana C. Ferreira Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal

Search for other papers by Joana C. Ferreira in
Google Scholar
PubMed
Close
,
Luísa Pereira Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal

Search for other papers by Luísa Pereira in
Google Scholar
PubMed
Close
,
Rui Batısta Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal

Search for other papers by Rui Batısta in
Google Scholar
PubMed
Close
,
Andre F. Vieira Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal

Search for other papers by Andre F. Vieira in
Google Scholar
PubMed
Close
,
Paula Soares Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal

Search for other papers by Paula Soares in
Google Scholar
PubMed
Close
,
Manuel Sobrinho Simões Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Abel Salazar Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal
Department of Pathology and Oncology, Centro Hospitalar São João, Porto, Portugal

Search for other papers by Manuel Sobrinho Simões in
Google Scholar
PubMed
Close
, and
Valdemar Máximo Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Porto, Portugal
Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal

Search for other papers by Valdemar Máximo in
Google Scholar
PubMed
Close

well-established driver mutations [ 1 , 2 ]. Papillary thyroid carcinoma (PTC), the most common type (i.e., 90% of all thyroid malignancies) probably contributes to most such tumours in this “dark zone” [ 3 ]. Approximately 90% of thyroid cancers

Free access
Shinsuke Shinkai Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Shinsuke Shinkai in
Google Scholar
PubMed
Close
,
Kenji Ohba Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan
Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Close
,
Kennichi Kakudo Department of Pathology and Thyroid Disease Center, Izumi City General Hospital, Osaka, Japan

Search for other papers by Kennichi Kakudo in
Google Scholar
PubMed
Close
,
Takayuki Iwaki Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Takayuki Iwaki in
Google Scholar
PubMed
Close
,
Yoshihiro Mimura Department of Internal Medicine, American Hospital of Paris, Neuilly sur Seine, France

Search for other papers by Yoshihiro Mimura in
Google Scholar
PubMed
Close
,
Akio Matsushita Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Close
,
Go Kuroda Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Go Kuroda in
Google Scholar
PubMed
Close
,
Yuki Sakai Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Yuki Sakai in
Google Scholar
PubMed
Close
,
Nobuhiko Nishino Department of Surgery, Maruyama Hospital, Shizuoka, Japan

Search for other papers by Nobuhiko Nishino in
Google Scholar
PubMed
Close
,
Kazuo Umemura Medical Education Center, Hamamatsu University School of Medicine, Shizuoka, Japan
Department of Pharmacology, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Kazuo Umemura in
Google Scholar
PubMed
Close
,
Takafumi Suda Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Close
, and
Shigekazu Sasaki Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan

Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
Close

common somatic mutation in papillary thyroid carcinoma). What Does This Case Report Add? • We identified concurrent BRAF mutation and TSHR polymorphism for the first time in a case of hyperfunctioning malignant thyroid nodule. • The findings

Free access
Ian D Hay Department of Medicine 1, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Ian D Hay in
Google Scholar
PubMed
Close
,
Suneetha Kaggal Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Suneetha Kaggal in
Google Scholar
PubMed
Close
, and
Geoffrey B Thompson Department of Surgery, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA

Search for other papers by Geoffrey B Thompson in
Google Scholar
PubMed
Close

Introduction Adults with low-risk ( 1 ) papillary thyroid carcinoma (PTC) represent the commonest endocrine malignancy ( 2 ). In 2017, Pontius and colleagues ( 3 ) demonstrated, in a study of 244,040 PTC patients managed in USA during 2004

Open access
Adile Begüm Bahçecioğlu Department of Endocrinology and Metabolism, Ankara University, School of Medicine, Ankara, Turkey

Search for other papers by Adile Begüm Bahçecioğlu in
Google Scholar
PubMed
Close
,
Alptekin Gürsoy Department of Endocrinology and Metabolism, Ankara Guven Hospital, Ankara, Turkey

Search for other papers by Alptekin Gürsoy in
Google Scholar
PubMed
Close
,
Serpil Dizbay Sak Department of Pathology, Ankara University, School of Medicine Ankara, Turkey

Search for other papers by Serpil Dizbay Sak in
Google Scholar
PubMed
Close
,
Seyfettin Ilgan Department of Nuclear Medicine, Ankara Guven Hospital, Ankara, Turkey

Search for other papers by Seyfettin Ilgan in
Google Scholar
PubMed
Close
,
Banu Bilezikçi Department of Pathology, Ankara Guven Hospital, Ankara, Turkey

Search for other papers by Banu Bilezikçi in
Google Scholar
PubMed
Close
, and
Murat Faik Erdoğan Department of Endocrinology and Metabolism, Ankara University, School of Medicine, Ankara, Turkey

Search for other papers by Murat Faik Erdoğan in
Google Scholar
PubMed
Close

Introduction Ultrasonographic (US) echogenic microfoci (EMF) are frequently seen in papillary thyroid carcinoma (PTC). European Thyroid Association, the American College of Radiology (ACR), and the Korean Society of Thyroid Radiology classify

Open access